INTERNATIONAL PATENT: PFIZER INC. FILES APPLICATION FOR "BENZODIAZEPINE COMPOUNDS AS N-PROTEIN INHIBITORS"

GENEVA, June 16 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192) filed a patent application (PCT/IB2024/062150) for "BENZODIAZEPINE COMPOUNDS AS N-PROTEIN INHIBITORS" on Dec 03, 2024. With publication no. WO/2025/120500, the details related to the patent application was published on Jun 12, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ADAMS, Jan Antoinette Cusi Romero (c/o Pfizer Inc.610 Main StreetCambridge, Massachusetts 02139), BARRETT, Matthew Jeremy (c/o Pfizer R&D UK LimitedRamsgate RoadSandwich Kent CT13 9NJ), BEDERNJAK, Alexandre Francois (c/o Pfizer R&D UK L...